Clinical assay validation for SARS-CoV-2 sequencing using Swift Biosciences amplicon panel
The current study used the guidelines of the FDA to validate the one-tube SARS-CoV-2 Swift Normalase Amplicon Panel Version 2.0 from Swift Biosciences.
United States Zita Shutterstock Drugs Administration Us Centers For Disease Clinical Laboratory Improvement Amendments Swift Normalase Amplicon Panel For Sensitive Recovery
Source: news-medical.net